Brief: Candel Therapeutics Q2 Net Income USD -22.237 Million
13/08/2024 13:00
Aug 13 (Reuters) - Candel Therapeutics Q2 basic EPS USD -0.74. * Q2 income from operations USD -8.571 million * Q2 operating expenses USD 8.571 million
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)